Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-17-310475
Filing Date
2017-10-16
Accepted
2017-10-16 09:33:02
Documents
9
Effectiveness Date
2017-10-16

Document Format Files

Seq Description Document Type Size
1 DEFA14A d474501ddefa14a.htm DEFA14A 32886
2 GRAPHIC g474501001.jpg GRAPHIC 42470
3 GRAPHIC g474501002.jpg GRAPHIC 24228
4 GRAPHIC g474501003.jpg GRAPHIC 7435
5 GRAPHIC g474501004.jpg GRAPHIC 19612
6 GRAPHIC g474501005.jpg GRAPHIC 8044
7 GRAPHIC g474501006.jpg GRAPHIC 2605
8 GRAPHIC g474501007.jpg GRAPHIC 3944
9 GRAPHIC g474501008.jpg GRAPHIC 4581
  Complete submission text file 0001193125-17-310475.txt   190546
Mailing Address 3611 VALLEY CENTER DRIVE SUITE 500 SAN DIEGO CA 92130
Business Address 3611 VALLEY CENTER DRIVE SUITE 500 SAN DIEGO CA 92130 858-792-6300
MEI Pharma, Inc. (Filer) CIK: 0001262104 (see all company filings)

IRS No.: 510407811 | State of Incorp.: DE | Fiscal Year End: 0630
Type: DEFA14A | Act: 34 | File No.: 000-50484 | Film No.: 171137789
SIC: 2834 Pharmaceutical Preparations